Log on / register
Feedback | Support | My details
Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies.
Vincent JL, Nadel S, Kutsogiannis DJ, Gibney RT, Yan SB, Wyss VL, Bailey JE, Mitchell CL, Sarwat S, Shinall SM, Janes JM
Crit Care 2005 Aug, 9:R331-43
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
37%37%


 Review
Practical aspects of treatment with drotrecogin alfa (activated)
Camporota L, Wyncoll D
Critical Care 2007, 11(Suppl 5):S7 (19 December 2007)
[Full text] [PubMed Central] [PubMed] [Related articles] [Cited on BioMed Central]
2.
37%37%


 Review
Year in review 2005: Critical Care resource management
Amaral ACKB, Rubenfeld GD
Critical Care 2006, 10:215 (29 June 2006)
[Full text] [PubMed Central] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.